| Name | Title | Contact Details |
|---|
RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.
Collaborative Imaging is a radiologist owned alliance conceived by forward thinking physicians in conjunction with proven business experts to combat the growing threat of consolidation in radiology, degradation in patient care, physician burn-out, and operational inefficiencies plaguing radiologists, while providing a sustainable business model to allow its partners to realize additional revenue opportunities, all while retaining their full autonomy as an independent radiology practice.
Avanti Benefits is a Morrisville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OtisMed Corporation is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
GreenTea HP is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.